Videos

From his own recovery to leading Illinois Recovery Center, Christopher Schenewerk, MD, shares he now champions peer support, naltrexone, and long-term care.

A transformative shift in addiction treatment and advocating for evidence-based approaches like naltrexone to offer personalized recovery paths beyond traditional abstinence models may be in the future for addiction treatment.

Panelists discuss how faster-acting treatments like zuranolone might improve patient outcomes and quality of life, the initial signs to monitor for assessing effectiveness, barriers to accessing such therapies in underserved populations and strategies to increase accessibility, approaches to ensuring safety while addressing distress in patients with intrusive thoughts, effective strategies for managing sleep issues in postpartum depression (PPD), advice for the psychiatry community when treating PPD, and how to tailor advice for clinicians working with underserved populations.

Panelists discuss when to adjust the dosage of current therapies like sertraline vs considering alternative treatments and the factors that guide these decisions, as well as whether treatments with rapid onset, such as zuranolone capsules or brexanolone intravenous (IV) infusion, would be appropriate for cases like Sarah’s, and what factors would influence the choice between these options.

Panelists discuss the case of Sarah, a 29-year-old woman with a history of major depressive disorder who is struggling with postpartum adjustment and increasing isolation, highlighting the challenges of transitioning into motherhood, family dynamics, and the potential genetic and environmental factors influencing her mental health.

Struggling with alcohol use or concerned about early signs of addiction? Identifying unhealthy drinking patterns early can make a difference.

"What did I know, what did I know of love’s austere and lonely offices?"

A professional's battle with alcoholism escalated from social drinking to daily dependence, impacting work and relationships until a pivotal moment led to seeking rehab and recovery.

Check out 2 high-level examples of patient quality of life improvement following treatment for tardive dyskinesia.

What are some of the best medical interventions for alcohol use disorder?

Did you watch the inauguration? What oaths do you personally take?

What are the signs of increased struggle with tardive dyskinesia? Here's what Erin Crown, MHS, PA-C, Psych-CAQ, picks up on during patient visits.

Tardive dyskinesia can be difficult to discern...

Here's how to address medication side effects with patients.

Here's why you should be paying attention to this new, upcoming Alzheimer disease treatment...

Learn how clinicians can better recognize, diagnose, and support patients struggling with addiction through proactive screening and honest conversations.

COVID-19 increased the usage of telemedicine drastically, but is that always a good thing?

A new report addressing misinformation in science lays out how we can best distinguish truth from fiction.

What 5 factors should you look at when selecting ADHD treatment?

How can a whole-patient approach improve treatment for alcohol use disorder (AUD)? Joseph Volpicelli, MD, PhD, shares expert insights on evidence-based strategies, patient collaboration, and the role of medications like naltrexone in long-term recovery.

Let's explore COVID-19's impact on psychiatric research...

Let's define success for patients with ADHD...

"Who are you important to? If you passed tomorrow, who would show up at your funeral?"

When a patient has comorbidities like anxiety, substance use, and depression, how can you best select a treatment?

Come celebrate the evolution of Psychiatric Times and psychiatry as a whole!

When prescribing ADHD medications, when is the best time to switch treatments?

Panelists discuss early signs of a positive response to treatment in postpartum depression (PPD), the specific symptoms to monitor, obstacles to accessing timely care in underserved populations, the role of family and community resources in recovery, key competencies for clinicians in addressing urgent PPD cases, and essential elements of a comprehensive, patient-centered treatment plan that balances medication, therapy, and support resources.

Panelists discuss the strategic decision-making process for choosing among selective serotonin reuptake inhibitors (SSRIs), rapid-onset treatments like zuranolone, and nonmedication therapies for postpartum depression (PPD), emphasizing the importance of treatment speed, severity of symptoms, and patient preferences.

How can we improve patient outcomes? Collaboration.

Ancillary symptoms may be key in guiding treatment management for ADHD.